Dental Pain (Following Third Molar Tooth Extraction) Study
| Status: | Completed |
|---|---|
| Conditions: | Dental |
| Therapuetic Areas: | Dental / Maxillofacial Surgery |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 1/20/2017 |
| Start Date: | December 2004 |
| End Date: | April 2005 |
A Pivotal Phase III, Single Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Dose-Ranging Study to Investigate the Efficacy and Safety of Single Oral Doses of 10mg, 25mg, 50mg and 70mg GW406381 and 550mg Naproxen Sodium in Subjects With Pain Following Third Molar Tooth Extraction
The purpose of this study is to evaluate the effectiveness of GW406381 (a COX-2 inhibitor)
in treating the signs and symptoms of dental pain following third molar tooth extraction.
in treating the signs and symptoms of dental pain following third molar tooth extraction.
A Pivotal Phase III, Single Center, Randomized, Double-Blind, Placebo-Controlled, Parallel
Group Dose-Ranging Study to Investigate the Efficacy and Safety of Single Oral Doses of
10mg, 25mg, 50mg, and 70mg GW406381 and 550mg Naproxen Sodium in Subjects With Pain
Following Third Molar Tooth Extraction
Group Dose-Ranging Study to Investigate the Efficacy and Safety of Single Oral Doses of
10mg, 25mg, 50mg, and 70mg GW406381 and 550mg Naproxen Sodium in Subjects With Pain
Following Third Molar Tooth Extraction
Inclusion criteria:
- Scheduled for outpatient surgical removal of at least two third molar teeth.
Exclusion criteria:
- Subjects who do not achieve moderate to severe pain.
- Subjects who do not use acceptable contraception.
- Additional medical criteria will be assessed by the investigator.
We found this trial at
1
site
Click here to add this to my saved trials
